Main Sequence Ventures Investor
Main Sequence Ventures invests in ambitious founders creating the next set of global industries leveraging deep tech or frontier technologies. The firm is backed by the Australian National Science Agency, CSIRO, the Australian Federal Government, and private investors. All Main Sequence investments leverage world-leading research from Australian public research organizations such as CSIRO, any of Australia's 41 universities or its multitude of other industry research agencies.
Founder: Bill Bartee,Martin Duursma,Mike Nicholls,Mike Zimmerman,Phil Morle
Number of Investments: 111
AUM 2026: A$500 million+
Key Partner: Phil Morle (Managing Partner)
.jpg)
%20.jpg)
%20.jpg)
Funding Status:
private
Headquarters:
Sydney,New South Wales,Australia,Oceania
Investor Type:
Venture Capital
Founded Date:
2017-07-01
Employee Number:
11-50